nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Goserelin—Mood swings—Methotrexate—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Goserelin—Nausea—Mometasone—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Goserelin—Anorexia—Lisinopril—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Goserelin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Goserelin—Weight increased—Prednisone—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Goserelin—Pain—Mycophenolic acid—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Goserelin—Constipation—Mycophenolic acid—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Goserelin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Goserelin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000616	0.000616	CcSEcCtD
Goserelin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Goserelin—Hypotension—Lisinopril—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Goserelin—Dizziness—Captopril—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Goserelin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Goserelin—Depression—Prednisone—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Goserelin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Goserelin—Urticaria—Leflunomide—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Goserelin—Abdominal pain—Leflunomide—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Goserelin—Body temperature increased—Leflunomide—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Goserelin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Goserelin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Goserelin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Goserelin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Goserelin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Goserelin—Myocardial infarction—Prednisone—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Goserelin—Breast disorder—Methotrexate—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Goserelin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Goserelin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Goserelin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Goserelin—Insomnia—Lisinopril—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Goserelin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000591	0.000591	CcSEcCtD
Goserelin—Paraesthesia—Lisinopril—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Goserelin—Vomiting—Captopril—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Goserelin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Goserelin—Dyspnoea—Lisinopril—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Goserelin—Rash—Captopril—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Goserelin—Dermatitis—Captopril—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Goserelin—Somnolence—Lisinopril—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Goserelin—Headache—Captopril—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Goserelin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Goserelin—Dyspepsia—Lisinopril—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Goserelin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Goserelin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Goserelin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Goserelin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Goserelin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Goserelin—Decreased appetite—Lisinopril—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Goserelin—Fatigue—Lisinopril—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Goserelin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Goserelin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Goserelin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Goserelin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Goserelin—Constipation—Lisinopril—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Goserelin—Pain—Lisinopril—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Goserelin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Goserelin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Goserelin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Goserelin—Diarrhoea—Azathioprine—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Goserelin—Haemoglobin—Prednisone—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Goserelin—Nausea—Captopril—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Goserelin—Haemorrhage—Prednisone—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Goserelin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Goserelin—Asthenia—Leflunomide—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Goserelin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Goserelin—Pruritus—Leflunomide—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Goserelin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Goserelin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Goserelin—Dysuria—Methotrexate—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Goserelin—Dizziness—Azathioprine—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Goserelin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Goserelin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Goserelin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Goserelin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Goserelin—Diarrhoea—Leflunomide—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Goserelin—Urticaria—Lisinopril—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Goserelin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Goserelin—Abdominal pain—Lisinopril—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Goserelin—Body temperature increased—Lisinopril—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Goserelin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000515	0.000515	CcSEcCtD
Goserelin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Goserelin—Vomiting—Azathioprine—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Goserelin—Pneumonia—Methotrexate—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Goserelin—Eye disorder—Prednisone—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Goserelin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Goserelin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Goserelin—Drowsiness—Methotrexate—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Goserelin—Rash—Azathioprine—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Goserelin—Dermatitis—Azathioprine—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Goserelin—Depression—Methotrexate—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Goserelin—Headache—Azathioprine—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Goserelin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Goserelin—Dizziness—Leflunomide—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Goserelin—Renal failure—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Goserelin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Goserelin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Goserelin—Angiopathy—Prednisone—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Goserelin—Immune system disorder—Prednisone—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Goserelin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Goserelin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Goserelin—Arrhythmia—Prednisone—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Goserelin—Sweating—Methotrexate—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Goserelin—Haematuria—Methotrexate—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Goserelin—Vomiting—Leflunomide—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Goserelin—Alopecia—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Goserelin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Goserelin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Goserelin—Rash—Leflunomide—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Goserelin—Dermatitis—Leflunomide—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Goserelin—Mental disorder—Prednisone—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Goserelin—Nausea—Azathioprine—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Goserelin—Headache—Leflunomide—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Goserelin—Erythema—Prednisone—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Goserelin—Malnutrition—Prednisone—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Goserelin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Goserelin—Asthenia—Lisinopril—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Goserelin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Goserelin—Pruritus—Lisinopril—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Goserelin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Goserelin—Haemoglobin—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Goserelin—Rash—Mycophenolic acid—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Goserelin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Goserelin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Goserelin—Headache—Mycophenolic acid—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Goserelin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Goserelin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Goserelin—Nausea—Leflunomide—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Goserelin—Vision blurred—Prednisone—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Goserelin—Diarrhoea—Lisinopril—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Goserelin—Anaemia—Prednisone—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Goserelin—Dizziness—Lisinopril—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Goserelin—Nausea—Mycophenolic acid—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Goserelin—Malaise—Prednisone—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Goserelin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Goserelin—Vomiting—Lisinopril—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Goserelin—Rash—Lisinopril—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Goserelin—Convulsion—Prednisone—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Goserelin—Dermatitis—Lisinopril—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Goserelin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Goserelin—Hypertension—Prednisone—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Goserelin—Chills—Methotrexate—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Goserelin—Headache—Lisinopril—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Goserelin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Goserelin—Myalgia—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Goserelin—Arthralgia—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Goserelin—Anxiety—Prednisone—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Goserelin—Alopecia—Methotrexate—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Goserelin—Discomfort—Prednisone—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Goserelin—Erythema—Methotrexate—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Goserelin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Goserelin—Nausea—Lisinopril—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Goserelin—Oedema—Prednisone—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Goserelin—Infection—Prednisone—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Goserelin—Back pain—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Goserelin—Shock—Prednisone—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Goserelin—Tachycardia—Prednisone—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Goserelin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Goserelin—Skin disorder—Prednisone—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Goserelin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000376	0.000376	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Goserelin—Anorexia—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Goserelin—Anaemia—Methotrexate—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Goserelin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Goserelin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Goserelin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Goserelin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Goserelin—Malaise—Methotrexate—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Goserelin—Insomnia—Prednisone—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Goserelin—Paraesthesia—Prednisone—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Goserelin—Cough—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Goserelin—Convulsion—Methotrexate—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Goserelin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Goserelin—Myalgia—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Goserelin—Chest pain—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Goserelin—Fatigue—Prednisone—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Goserelin—Discomfort—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Goserelin—Constipation—Prednisone—systemic scleroderma	0.000332	0.000332	CcSEcCtD
Goserelin—Confusional state—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Goserelin—Infection—Methotrexate—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Goserelin—Feeling abnormal—Prednisone—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Goserelin—Anorexia—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Goserelin—Urticaria—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Goserelin—Hypotension—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Goserelin—Insomnia—Methotrexate—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Goserelin—Somnolence—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Goserelin—Hypersensitivity—Prednisone—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Goserelin—Fatigue—Methotrexate—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Goserelin—Asthenia—Prednisone—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Goserelin—Pain—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Goserelin—Pruritus—Prednisone—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Goserelin—Diarrhoea—Prednisone—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Goserelin—Urticaria—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Goserelin—Dizziness—Prednisone—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Goserelin—Vomiting—Prednisone—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Goserelin—Rash—Prednisone—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Goserelin—Dermatitis—Prednisone—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Goserelin—Headache—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Goserelin—Asthenia—Methotrexate—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Goserelin—Nausea—Prednisone—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Goserelin—Pruritus—Methotrexate—systemic scleroderma	0.00023	0.00023	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Goserelin—Dizziness—Methotrexate—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Goserelin—Vomiting—Methotrexate—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Goserelin—Rash—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Goserelin—Headache—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Goserelin—Nausea—Methotrexate—systemic scleroderma	0.000193	0.000193	CcSEcCtD
